Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.25p
   
  • Change Today:
      0.005p
  • 52 Week High: 1.22
  • 52 Week Low: 0.20
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 1,015,401
  • Market Cap: £5.26m
  • Beta: 0.00

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
11-Sep-18 Northland Capital Partners Buy 15.75p - 113.00p Reiteration
27-Jul-18 Northland Capital Partners Buy 17.00p - 113.00p Reiteration
11-Jun-18 Northland Capital Partners Buy 22.10p - 113.00p Reiteration
04-May-18 Northland Capital Partners Buy 19.00p 113.00p 113.00p Reiteration
05-Mar-18 Northland Capital Partners Corporate 14.75p - - Reiteration
04-Jan-16 Northland Capital Partners Buy 23.25p - 79.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.25p
Change Today 0.005p
% Change -2.00 %
52 Week High 1.22
52 Week Low 0.20
Volume 1,015,401
Shares Issued 2,148.96m
Market Cap £5.26m
Beta 0.00

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.79% above the market average13.79% above the market average13.79% above the market average13.79% above the market average13.79% above the market average
90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average
Price Trend
86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average
72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average
Income Not Available
Growth Not Available

Theracryf Dividends

No dividends found

Trades for 18-Sep-2025

Time Volume / Share Price
16:39 1,000,000 @ 0.24p
13:28 1,923 @ 0.26p
11:43 2,000 @ 0.23p
09:27 519 @ 0.23p
09:27 7,692 @ 0.26p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page